Celularity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celularity and other ETFs, options, and stocks.About CELU
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.
CEORobert Joseph Hariri Gordon
CEORobert Joseph Hariri Gordon
Employees123
Employees123
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2016
Founded2016
Employees123
Employees123
CELU Key Statistics
Market cap55.89M
Market cap55.89M
Price-Earnings ratio-0.59
Price-Earnings ratio-0.59
Dividend yield—
Dividend yield—
Average volume61.02K
Average volume61.02K
High today$2.01
High today$2.01
Low today$1.95
Low today$1.95
Open price$1.99
Open price$1.99
Volume46.09K
Volume46.09K
52 Week high$4.35
52 Week high$4.35
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
Celularity(CELU) stock is priced at $1.97, giving the company a market capitalization of 55.89M. It carries a P/E multiple of -0.59.
As of 2025-12-05, Celularity(CELU) stock has fluctuated between $1.95 and $2.01. The current price stands at $1.97, placing the stock +1.0% above today's low and -2.0% off the high.
Celularity(CELU) shares are trading with a volume of 46.09K, against a daily average of 61.02K.
During the past year, Celularity(CELU) stock moved between $1.00 at its lowest and $4.35 at its peak.
During the past year, Celularity(CELU) stock moved between $1.00 at its lowest and $4.35 at its peak.
People also own
Based on the portfolios of people who own CELU. This list is generated using Robinhood data, and it’s not a recommendation.